Company: WHWK
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001628280-25-020311
Chunk: 27

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 27
---
 competitive so that we are able to recruit and retain qualified directors. We have adopted an outside director compensation policy, last amended and restated in May 2024, that provides for certain compensation to our non-employee directors (as amended the “Director Compensation Policy”), pursuant to which our non-employee directors will receive cash compensation, paid quarterly, as follows:

• Each non-employee director is entitled to receive an annual cash retainer in the amount of $40,000 per year.

• A non-employee chairperson is entitled to receive an additional annual cash retainer in the amount of $26,000 per year.

• The chairperson of the audit committee is entitled to receive additional annual cash compensation in the amount of $20,000 per year for such chairperson’s service on the audit committee. Each other member of the audit committee is entitled to receive additional annual cash compensation in the amount of $8,000 per year for such member’s service on the audit committee.

• The chairperson of the compensation committee is entitled to receive additional annual cash compensation in the amount of $12,000 per year for such chairperson’s service on the compensation committee. Each other member of the compensation committee is entitled to receive additional annual cash compensation in the amount of $6,000 per year for such member’s service on the compensation committee.

• The chairperson of the nominating and corporate governance committee is entitled to receive additional annual cash compensation in the amount of $9,000 per year for such chairperson’s service on the nominating and corporate governance committee. Each other member of the nominating and corporate governance committee is entitled to receive additional annual cash compensation in the amount of $4,500 per year for such member’s service on the nominating and corporate governance committee.

Upon a non-employee director’s initial appointment or election to our Board, that person will receive an option (the “Initial Grant”) to purchase shares of our common stock with an aggregate grant date fair value as determined in accordance with U.S. generally accepted accounting principles equal to $106,000 (decreased in May 2024 from $325,000). The Initial Grant will vest as to one thirty-sixth (1/36 th ) of the shares subject to the Initial Grant on a monthly basis following the Initial Grant’s grant date on the same day of the month as such grant date, subject to continued service through each applicable vesting date.

In addition, each non-employee director who has been serving as a director for the prior six months and